189 related articles for article (PubMed ID: 16600302)
1. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
Moalem J; Davidov T; Zhang Q; Grover GJ; Weiss HR; Scholz PM
J Surg Res; 2006 Sep; 135(1):38-44. PubMed ID: 16600302
[TBL] [Abstract][Full Text] [Related]
2. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
[TBL] [Abstract][Full Text] [Related]
3. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
[TBL] [Abstract][Full Text] [Related]
4. Effects of cyclic GMP and its protein kinase on the contraction of ventricular myocytes from hearts after cardiopulmonary arrest.
Su J; Scholz PM; Tse J; Weiss HR
Can J Physiol Pharmacol; 2004 Nov; 82(11):986-92. PubMed ID: 15644938
[TBL] [Abstract][Full Text] [Related]
5. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
6. Brain natriuretic peptide reverses the effects of myocardial stunning in rabbit myocardium.
Anyadike C; Scholz PM; Zhang Q; Katz E; Weiss HR
Pharmacology; 2007; 80(1):40-8. PubMed ID: 17519532
[TBL] [Abstract][Full Text] [Related]
7. Importance of ryanodine receptors in effects of cyclic GMP is reduced in thyroxine-induced cardiac hypertrophy.
Zhang Q; Goel N; Rodriguez R; Scholz PM; Weiss HR
Eur J Pharmacol; 2006 May; 537(1-3):45-51. PubMed ID: 16626695
[TBL] [Abstract][Full Text] [Related]
8. Functional interaction of a beta-adrenergic agonist and cyclic GMP phosphodiesterase inhibitor in control and hypertrophic cardiomyocytes.
Zhang S; Rodriguez R; Scholz PM; Weiss HR
Pharmacology; 2006; 76(2):53-60. PubMed ID: 16276122
[TBL] [Abstract][Full Text] [Related]
9. Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts.
Su J; Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1367-73. PubMed ID: 15550520
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytes.
Tan T; Scholz PM; Weiss HR
Life Sci; 2010 Jul; 87(1-2):9-16. PubMed ID: 20470788
[TBL] [Abstract][Full Text] [Related]
11. Cyclic GMP signaling and regulation of SERCA activity during cardiac myocyte contraction.
Zhang Q; Scholz PM; He Y; Tse J; Weiss HR
Cell Calcium; 2005 Mar; 37(3):259-66. PubMed ID: 15670873
[TBL] [Abstract][Full Text] [Related]
12. Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit cardiac myocytes.
Straznicka M; Gong G; Yan L; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 1999 Aug; 34(2):229-36. PubMed ID: 10445674
[TBL] [Abstract][Full Text] [Related]
13. T4-induced cardiac hypertrophy disrupts cyclic GMP mediated responses to brain natriuretic peptide in rabbit myocardium.
Katz E; Zhang Q; Weiss HR; Scholz PM
Peptides; 2006 Sep; 27(9):2276-83. PubMed ID: 16762459
[TBL] [Abstract][Full Text] [Related]
14. Negative functional effects of cGMP mediated by cGMP protein kinase are reduced in T4 cardiac myocytes.
Engel S; Yan L; Weiss H; Scholz P
Eur J Pharmacol; 2001 Jun; 421(1):23-30. PubMed ID: 11408045
[TBL] [Abstract][Full Text] [Related]
15. Alterations in ventricular myocyte contraction caused by C-type natriuretic peptide and nitric oxide in eNOS-/- mice.
Su J; Tse J; Scholz PM; Weiss HR
J Mol Cell Cardiol; 2005 Dec; 39(6):920-8. PubMed ID: 16236310
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
[TBL] [Abstract][Full Text] [Related]
17. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
[TBL] [Abstract][Full Text] [Related]
18. Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I.
Wollert KC; Yurukova S; Kilic A; Begrow F; Fiedler B; Gambaryan S; Walter U; Lohmann SM; Kuhn M
Br J Pharmacol; 2003 Dec; 140(7):1227-36. PubMed ID: 14609817
[TBL] [Abstract][Full Text] [Related]
19. Reduced myocardial cyclic GMP increases myocardial O2 consumption in control but not renal hypertension-induced cardiac hypertrophy.
Sadoff JD; Scholz PM; Tse J; Weiss HR
Cardiovasc Res; 1997 Dec; 36(3):453-9. PubMed ID: 9534866
[TBL] [Abstract][Full Text] [Related]
20. C-type natriuretic peptide has a negative inotropic effect on cardiac myocytes.
Nir A; Zhang DF; Fixler R; Burnett JC; Eilam Y; Hasin Y
Eur J Pharmacol; 2001 Feb; 412(3):195-201. PubMed ID: 11166282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
